Application challenges and examples of new excipients in advanced drug delivery systems

American Pharmaceutical Review

Volumn 14, Issue 2, 2011, Pages 60-68

  Koo, Otilia M Y ^a,b  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CROSPOVIDONE; DAUNORUBICIN; DENDRIMER; DOXORUBICIN; EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; LIPOSOME; MICROCRYSTALLINE CELLULOSE; NANOCRYSTAL; PACLITAXEL; POVIDONE; RAPAMYCIN;

CONFERENCE PAPER; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; MICELLE; NANOEMULSION; NANOTECHNOLOGY;

EID: 79953236320     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Koo OMY. Advances and Examples of New Excipients in Novel Drug Delivery Systems. Presented at: Annual Meeting of the American Association of Pharmaceutical Scientists. New Orleans, LA, USA, 14-18 November 2010.
2. Food and Drug Administration. Guidance for Industry: Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients. (2005)
3. Koo OMY and Varia SA. Case Studies with New Excipients: Development, Implementation and Regulatory Approval. Therapeutic Delivery. Submitted (2011)
4. Moreton RC. Functionality and Performance of Excipients in a Quality-by-Design World, Part IX: New Excipients. American Pharmaceutical Review Apr 34-37 (2010)
5. Moreton RC. Tablet Excipients to the Year 2001: A Look into the Crystal Ball. Drug Development and Industrial Pharmacy, 22( l), 1-23 ( 1996)
6. Nachaegari SK, Bansal AK. Coprocessed Excipients for Solid Dosage Forms. Pharmaceutical Technology Jan, 52-64 (2004)
7. Block LH et al. Co-processed Excipients. Pharmacopeial Forum 35(4) 1026-1028 (2009)
8. Sheskey PJ, Williams DM. Comparison of Low-Shear and High-Shear Wet Granulation Techniques and the Influence of Percent Water Addition in the Preparation of a Controlled-Release Matrix Tablet Containing HPMC and a High-Dose, Highly Water-Soluble Drug. Pharmaceutical Technology MARCH 81-92 (1996)
9. Huang Y, Khanvilkar KH, Moore AD, Hilliard-Lott M. Effects of Manufacturing Process Variables on In Vitro Dissolution Characteristics of Extended-Release Tablets Formulated with Hydroxypropyl Methylcellulose. Drug Development and Industrial Pharmacy 29 (1) 79-88 (2003)
10. Ender K, Cabelka T, Jacob K, Denomme D, Wallick D. A New Hypromellose Excipient for Direct Compression Controlled Release Applications. AAPS Annual Meeting Abstract # 002440 (2007)
11. Wu Y, Levons J, Fu W, Rao V. Profiling of Reactive Impurities in Pharmaceutical Excipients - Implications on Drug-Excipient Interactions. AAPS Annual Meeting Abstract # 002404 (2007)
12. Van Arnum P. Formulation Development Forum: Analysis of Crospovidone as a Superdistingrant. Pharmaceutical Technology 35, Issue 1, 50 (2011)
13. National Nanotechnology Initiative Strategic Plan. http://www.nano.gov/ nnistrategicplan211.pdf
14. Koo OMY, Rubinstein I, Onyuksel H. Role of Nanotechnology in Targeted Drug Delivery and Imaging: A Concise Review. Nanomedicine: Nanotechnology, Biology, and Medicine 1 193-212 (2005)
15. Koo O, Rubinstein I, Onyuksel H, "Camptothecin in Sterically Stabilized Micelles: A Novel Nanomedicine", Nanomedicine: Nanotechnology, Biology, and Medicine 1 77-84 (2005).
16. Velagaleti R. Excipient Innovation and Regulatory Acceptance for Use in Drug Products- Solubilizer Solutol® HS 15 Case Study. Presented at: Annual Meeting of the American Association of Pharmaceutical Scientists. Los Angeles, CA, USA, November (2009)
17. Brewster ME, Loftsson T. Cyclodextrins as Pharmaceutical Solubilizers. Advanced Drug Delivery Reviews 59 645-666 (2007)
18. Van Eerdenbrugh B, Taylor LS. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation. Molecular Pharmaceutics 7(4) 1328-1337 (2010)
19. Serajuddin ATM. Solid Dispersion of Poorly Water-Soluble Drugs: Early Promises, Subsequent Problems, and Recent Breakthroughs. Journal of Pharmaceutical Sciences 88 (10) 1058-1066 (1999)
20. BASF product brochure: Kollicoat® Smartseal 30 D - Active Protection.
21. Svenson S, Tomalia DA. Dendrimers in Biomedical Applications - Reflections on the Field. Advanced Drug Delivery Reviews 57 2106-2129 (2005)
22. David S, Pitard B, Benoita J-P, Passirania C. Non-viral Nanosystems for Systemic siRNA Delivery. Pharmacological Research 62 100-114 (2010)